Platform

Patent Portfolio

Senhwa’s patent portfolio is comprised of 156 issued patents and 54 pending patent applications. Intellectual property rights include patents covering product derivatives, pharmaceutical formulations, method of use, manufacturing process, crystalline forms and combination therapies.

Patents have been granted mainly in the US, Europe, Canada, Japan, South Korea, Mainland China, Australia, New Zealand and Taiwan.

• Brazil

  2

• India

  5

• ASEAN

  12

• Taiwan

  7

• Russia

  6

• Israel

  5

• New Zealand

  5

• China

  7

• South Korea

  7

• Japan

  9

• Hong Kong

  10

• Canada

  9

• Australia

  10

• United States

  22

• Europe

  101